Caxton Associates LLP Trans Medics Group, Inc. Transaction History
Caxton Associates LLP
- $3.94 Trillion
- Q2 2025
A detailed history of Caxton Associates LLP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 1,808 shares of TMDX stock, worth $209,167. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,808Holding current value
$209,167% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
415Shares Held
29.8MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$306 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$149 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$122 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$111 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.68B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...